# Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy

> **NCT03697850** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **UNICANCER** · enrollment: 79 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Atezolizumab

## Key facts

- **NCT ID:** NCT03697850
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-12-14
- **Primary completion:** 2025-06-15
- **Final completion:** 2029-02-15
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2025-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03697850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03697850, "Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03697850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*